1. Endo thinks it has the financial flexibility to weather the storm of opioid settlements — Takeda acquires celiac-focused PvP Biologics — Iovance jumps on buyout rumors — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Guided Therapeutics

Anonymous board for Guided Therapeutics


Sort By:
Title
Replies Views
Last Message ↓
  1. Anonymous
    Replies:
    0
    Views:
    4,584
  2. Anonymous
    Replies:
    1
    Views:
    2,728
  3. vsun
    Replies:
    2
    Views:
    3,078
  4. Anonymous
    Replies:
    0
    Views:
    2,463
  5. Anonymous
    Replies:
    1
    Views:
    4,498
  6. Anonymous
    Replies:
    0
    Views:
    2,815
  7. Anonymous
    Replies:
    10
    Views:
    7,597
  8. Anonymous
    Replies:
    0
    Views:
    3,186
  9. Anonymous
    Replies:
    2
    Views:
    4,462
  10. Anonymous
    Replies:
    1
    Views:
    4,962

Thread Display Options

Loading...